Physician profile
Patrick A Patterson
NPI 1306891015
$5,780.77
in general payments reported to CMS, 2019-2025
14 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $263 · 2021: $339 · 2022: $154 · 2023: $3,260 · 2024: $699 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,221 · Food and Beverage: $2,198 · Entertainment: $20.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,220.53 |
| Food and Beverage | $2,198.47 |
| Entertainment | $20.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,314.84 | 2023 | Cirrus 5000 With Angioplex, Cirrus Hd-Oct |
| Johnson & Johnson Vision Care, INC. | $1,223.23 | 2023-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $504.51 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $502.16 | 2023-2025 | Infuse, Victus, Miebo |
| Alcon Vision LLC | $374.81 | 2020-2025 | Hydrus Microstent, Precision7 |
| Glaukos Corporation | $338.34 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $140.91 | 2024-2025 | |
| Coopervision INC. | $106.66 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Optos, INC. | $94.19 | 2022-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Ocular Therapeutix, INC. | $54.18 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $46.64 | 2025 | Xdemvy |
| Staar Surgical Company | $38.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.61 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.